General Manager, France.
We are currently hiring for the following positions:
Global Blood Therapeutics, Inc.
The health and safety of patients, healthcare professionals and our employees is our highest priority. Learn more about our response to the COVID-19 pandemic, including the direct support we are providing to the sickle cell disease community.
COVID-19 Information and Resources
Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. Founded in 2011, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited blood disorder. The company has introduced Oxbryta ® (Voxelotor), the first FDA-approved treatment that directly inhibits sickle hemoglobin polymerization, an underlying cause of SCD. GBT is also advancing its pipeline program in SCD with inclacumab, a p-selectin inhibitor in development to address pain crises associated with the disease. In addition, GBT’s drug discovery teams are working on new targets to develop the next generation of treatments for SCD. We are currently expanding our geographic footprint to Europe. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news .
This Paris-based position leads the Company Operations in France, inclusive of all commercial, access, pricing, medical, and customer interaction aspects, working with an external local exploitant. Furthermore, the General Manager provides input and guidance to employees in support functions. To that end, this role sets the vision for the French business, leads and coaches the local office and field team members taking accountability for the commercial success of GBT in France. The position reports to the Head of Europe.
Essential Duties and Responsibilities:
• Being a member of the Euro...
- Type d'emploi
- Temps plein